Elevation Oncology Inc (ELEV)

Not featured in screeners

Not featured in screeners

Ticker: ELEV Exchange: NSM

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Download results Settings

venBio Global Strategic Fund III, L.P.

1 sale — total 2,897,806 USD

Sale 25 May 2022

Value US$3,794,147.27 | Price 260.92 | Shares 48,056

Vertex Global HC Fund II Pte. Ltd.

1 purchase — total 4,000,000 USD

Buy 29 Jun 2021

Value US$3,915,971.17 | Price 85.34 | Shares 18,169

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2022-05-27	2022-05-25	S Sale	2.9 venBio Global Strategic Fund III, L.P. Large shareholder	48,056 -45.5% 260.92 US$3,794,147	48,056 -45.5%	260.92	US$3,794,147
2021-06-29	2021-06-29	B Purchase	Vertex Global HC Fund II Pte. Ltd. Large shareholder	18,169 +6.4% 85.34 US$3,915,971	18,169 +6.4%	85.34	US$3,915,971

More insider trading research around Elevation Oncology Inc